Prot #INS1007-221: A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Brensocatib in Participants with Chronic Rhinosinusitis Without Nasal Polyps – The BiRCh Study

Project: Research project

Project Details

StatusActive
Effective start/end date7/9/247/9/27

Funding

  • PPD Development (Prot #INS1007-221 // Prot #INS1007-221)
  • Insmed Incorporated (Prot #INS1007-221 // Prot #INS1007-221)